company background image
PARD3 logo

Instituto Hermes Pardini BOVESPA:PARD3 Stock Report

Last Price

R$20.25

Market Cap

R$2.6b

7D

2.3%

1Y

15.3%

Updated

29 Apr, 2023

Data

Company Financials +

Instituto Hermes Pardini S.A.

BOVESPA:PARD3 Stock Report

Market Cap: R$2.6b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

PARD3 Stock Overview

Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil.

PARD3 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends3/6

Instituto Hermes Pardini S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Instituto Hermes Pardini
Historical stock prices
Current Share PriceR$20.25
52 Week HighR$24.69
52 Week LowR$16.60
Beta0.87
1 Month Change0.35%
3 Month Change1.86%
1 Year Change15.32%
3 Year Change4.11%
5 Year Change-19.03%
Change since IPO-2.17%

Recent News & Updates

Recent updates

Why We Like The Returns At Instituto Hermes Pardini (BVMF:PARD3)

Jul 01
Why We Like The Returns At Instituto Hermes Pardini (BVMF:PARD3)

What Does Instituto Hermes Pardini S.A.'s (BVMF:PARD3) Share Price Indicate?

Jun 10
What Does Instituto Hermes Pardini S.A.'s (BVMF:PARD3) Share Price Indicate?

We Think Instituto Hermes Pardini's (BVMF:PARD3) Profit Is Only A Baseline For What They Can Achieve

Feb 17
We Think Instituto Hermes Pardini's (BVMF:PARD3) Profit Is Only A Baseline For What They Can Achieve

At R$22.16, Is It Time To Put Instituto Hermes Pardini S.A. (BVMF:PARD3) On Your Watch List?

Jan 31
At R$22.16, Is It Time To Put Instituto Hermes Pardini S.A. (BVMF:PARD3) On Your Watch List?

Does Instituto Hermes Pardini (BVMF:PARD3) Have A Healthy Balance Sheet?

Aug 19
Does Instituto Hermes Pardini (BVMF:PARD3) Have A Healthy Balance Sheet?

Is Now An Opportune Moment To Examine Instituto Hermes Pardini S.A. (BVMF:PARD3)?

Jun 08
Is Now An Opportune Moment To Examine Instituto Hermes Pardini S.A. (BVMF:PARD3)?

Should You Be Adding Instituto Hermes Pardini (BVMF:PARD3) To Your Watchlist Today?

May 22
Should You Be Adding Instituto Hermes Pardini (BVMF:PARD3) To Your Watchlist Today?

Here's What You Should Know About Instituto Hermes Pardini S.A.'s (BVMF:PARD3) 1.3% Dividend Yield

Apr 19
Here's What You Should Know About Instituto Hermes Pardini S.A.'s (BVMF:PARD3) 1.3% Dividend Yield

The Returns On Capital At Instituto Hermes Pardini (BVMF:PARD3) Don't Inspire Confidence

Apr 02
The Returns On Capital At Instituto Hermes Pardini (BVMF:PARD3) Don't Inspire Confidence

Instituto Hermes Pardini (BVMF:PARD3) Has A Pretty Healthy Balance Sheet

Mar 16
Instituto Hermes Pardini (BVMF:PARD3) Has A Pretty Healthy Balance Sheet

Is Instituto Hermes Pardini S.A.'s (BVMF:PARD3) Recent Performance Tethered To Its Attractive Financial Prospects?

Feb 08
Is Instituto Hermes Pardini S.A.'s (BVMF:PARD3) Recent Performance Tethered To Its Attractive Financial Prospects?

Would Shareholders Who Purchased Instituto Hermes Pardini's (BVMF:PARD3) Stock Three Years Be Happy With The Share price Today?

Jan 19
Would Shareholders Who Purchased Instituto Hermes Pardini's (BVMF:PARD3) Stock Three Years Be Happy With The Share price Today?

We're Watching These Trends At Instituto Hermes Pardini (BVMF:PARD3)

Dec 28
We're Watching These Trends At Instituto Hermes Pardini (BVMF:PARD3)

We Think Instituto Hermes Pardini (BVMF:PARD3) Can Stay On Top Of Its Debt

Dec 10
We Think Instituto Hermes Pardini (BVMF:PARD3) Can Stay On Top Of Its Debt

Instituto Hermes Pardini S.A. Just Beat Revenue By 6.5%: Here's What Analysts Think Will Happen Next

Nov 21
Instituto Hermes Pardini S.A. Just Beat Revenue By 6.5%: Here's What Analysts Think Will Happen Next

Our Take On The Returns On Capital At Instituto Hermes Pardini (BVMF:PARD3)

Sep 12
Our Take On The Returns On Capital At Instituto Hermes Pardini (BVMF:PARD3)

Does Instituto Hermes Pardini (BVMF:PARD3) Have A Healthy Balance Sheet?

Aug 25
Does Instituto Hermes Pardini (BVMF:PARD3) Have A Healthy Balance Sheet?

Investor Optimism Abounds Instituto Hermes Pardini S.A. (BVMF:PARD3) But Growth Is Lacking

Aug 07
Investor Optimism Abounds Instituto Hermes Pardini S.A. (BVMF:PARD3) But Growth Is Lacking

At R$28.99, Is It Time To Put Instituto Hermes Pardini S.A. (BVMF:PARD3) On Your Watch List?

Aug 06
At R$28.99, Is It Time To Put Instituto Hermes Pardini S.A. (BVMF:PARD3) On Your Watch List?

New Forecasts: Here's What Analysts Think The Future Holds For Instituto Hermes Pardini S.A. (BVMF:PARD3)

Jul 24
New Forecasts: Here's What Analysts Think The Future Holds For Instituto Hermes Pardini S.A. (BVMF:PARD3)

Is Now The Time To Put Instituto Hermes Pardini (BVMF:PARD3) On Your Watchlist?

Jul 12
Is Now The Time To Put Instituto Hermes Pardini (BVMF:PARD3) On Your Watchlist?

Instituto Hermes Pardini S.A. (BVMF:PARD3) Vies For A Place In Your Dividend Portfolio: Here's Why

Jun 29
Instituto Hermes Pardini S.A. (BVMF:PARD3) Vies For A Place In Your Dividend Portfolio: Here's Why

Shareholder Returns

PARD3BR HealthcareBR Market
7D2.3%-4.5%-0.5%
1Y15.3%10.7%17.7%

Return vs Industry: PARD3 exceeded the BR Healthcare industry which returned -44.6% over the past year.

Return vs Market: PARD3 exceeded the BR Market which returned -13.1% over the past year.

Price Volatility

Is PARD3's price volatile compared to industry and market?
PARD3 volatility
PARD3 Average Weekly Movement4.2%
Healthcare Industry Average Movement5.7%
Market Average Movement4.7%
10% most volatile stocks in BR Market8.1%
10% least volatile stocks in BR Market2.2%

Stable Share Price: PARD3 has not had significant price volatility in the past 3 months.

Volatility Over Time: PARD3's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19597,500Roberto Meirelleshttps://www.hermespardini.com.br

Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. The company offers precision medicine, medical imaging, and unprecedented differentials in the field of forensic toxicology, occupational medicine, and clinical medicine, as well as sample collection services for clinical analysis tests, imaging tests, and vaccines. In addition, it engages in the resale of laboratory test supplies; personalized medicine diagnosis; and pathological anatomy business.

Instituto Hermes Pardini S.A. Fundamentals Summary

How do Instituto Hermes Pardini's earnings and revenue compare to its market cap?
PARD3 fundamental statistics
Market capR$2.57b
Earnings (TTM)R$172.67m
Revenue (TTM)R$2.10b

14.9x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PARD3 income statement (TTM)
RevenueR$2.10b
Cost of RevenueR$1.53b
Gross ProfitR$571.04m
Other ExpensesR$398.37m
EarningsR$172.67m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.36
Gross Margin27.21%
Net Profit Margin8.23%
Debt/Equity Ratio53.3%

How did PARD3 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

4%

Payout Ratio

Does PARD3 pay a reliable dividends?

See PARD3 dividend history and benchmarks
When do you need to buy PARD3 by to receive an upcoming dividend?
Instituto Hermes Pardini dividend dates
Ex Dividend DateMay 02 2023
Dividend Pay DateMay 30 2023
Days until Ex dividend331 days
Days until Dividend pay date303 days

Does PARD3 pay a reliable dividends?

See PARD3 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.